Author

Bárbara Morão

MICROPERFORATION DURING ENDOSCOPIC SUBMUCOSAL DISSECTION: TO TREAT OR NOT TO TREAT?
MICROPERFORATION DURING ENDOSCOPIC SUBMUCOSAL DISSECTION: TO TREAT OR NOT TO TREAT?

Bárbara Morão  et al.

SECONDARY SCLEROSING CHOLANGITIS IN A CRITICALLY-ILL PATIENT PRECIPITATED BY SARS-COV2 INFECTION
SECONDARY SCLEROSING CHOLANGITIS IN A CRITICALLY-ILL PATIENT PRECIPITATED BY SARS-COV2 INFECTION

Bárbara Morão  et al.

A NOVEL TECHNOLOGY FOR MOLECULAR PROFILING OF KRAS GENE IN TUMOR SAMPLES AND LIQUID BIOPSIES IN PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA
A NOVEL TECHNOLOGY FOR MOLECULAR PROFILING OF KRAS GENE IN TUMOR SAMPLES AND LIQUID BIOPSIES IN PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA

CHRONIC HEPATITIS B GENOTYPE E: A REALITY IN A DISTRICT HOSPITAL IN PORTUGAL
CHRONIC HEPATITIS B GENOTYPE E: A REALITY IN A DISTRICT HOSPITAL IN PORTUGAL

Bárbara Morão  et al.

A NOVEL TECHNOLOGY FOR MOLECULAR PROFILING OF KRAS GENE IN TUMOR SAMPLES AND LIQUID BIOPSIES IN PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA
A NOVEL TECHNOLOGY FOR MOLECULAR PROFILING OF KRAS GENE IN TUMOR SAMPLES AND LIQUID BIOPSIES IN PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA

Bárbara Morão  et al.

INTRAHEPATIC CHOLESTASIS OF PREGNANCY – WHAT COMES NEXT?
INTRAHEPATIC CHOLESTASIS OF PREGNANCY – WHAT COMES NEXT?

Bárbara Morão  et al.

INTRAHEPATIC CHOLESTASIS OF PREGNANCY - WHAT COMES NEXT?
INTRAHEPATIC CHOLESTASIS OF PREGNANCY - WHAT COMES NEXT?

CHRONIC HEPATITIS B GENOTYPE E: CLINICAL CHARACTERISTICS AND RESPONSE TO ANTI-VIRAL AGENTS
CHRONIC HEPATITIS B GENOTYPE E: CLINICAL CHARACTERISTICS AND RESPONSE TO ANTI-VIRAL AGENTS

IGG4-RELATED HEPATIC INFLAMMATORY PSEUDOTUMOR MIMICKING MALIGNANCY
IGG4-RELATED HEPATIC INFLAMMATORY PSEUDOTUMOR MIMICKING MALIGNANCY

Bárbara Morão  et al.

CHRONIC HEPATITIS B GENOTYPE E: CLINICAL CHARACTERISTICS AND RESPONSE TO ANTI-VIRAL AGENTS
CHRONIC HEPATITIS B GENOTYPE E: CLINICAL CHARACTERISTICS AND RESPONSE TO ANTI-VIRAL AGENTS

Bárbara Morão  et al.

CHRONIC HEPATITIS B GENOTYPE E: A REALITY IN A DISTRICT HOSPITAL IN PORTUGAL
CHRONIC HEPATITIS B GENOTYPE E: A REALITY IN A DISTRICT HOSPITAL IN PORTUGAL

SECONDARY SCLEROSING CHOLANGITIS IN A CRITICALLY-ILL PATIENT PRECIPITATED BY SARS-COV2 INFECTION
SECONDARY SCLEROSING CHOLANGITIS IN A CRITICALLY-ILL PATIENT PRECIPITATED BY SARS-COV2 INFECTION

PROGNOSTIC VALUE OF AGRIN EXPRESSION IN PATIENTS WITH PANCREATIC CANCER
PROGNOSTIC VALUE OF AGRIN EXPRESSION IN PATIENTS WITH PANCREATIC CANCER

Bárbara Morão  et al.

RADIATION DOSE OPTIMIZATION IN ERCP: PROSPECTIVE INTERVENTIONAL STUDY
RADIATION DOSE OPTIMIZATION IN ERCP: PROSPECTIVE INTERVENTIONAL STUDY

Bárbara Morão  et al.

EPIDEMIOLOGY OF MULTIDRUG-RESISTANT INFECTIONS IN PATIENTS WITH CIRRHOSIS HOSPITALIZED IN A GASTROENTEROLOGY DEPARTMENT IN PORTUGAL
EPIDEMIOLOGY OF MULTIDRUG-RESISTANT INFECTIONS IN PATIENTS WITH CIRRHOSIS HOSPITALIZED IN A GASTROENTEROLOGY DEPARTMENT IN PORTUGAL

Bárbara Morão  et al.

HEPATITIS B REACTIVATION DURING HEPATITIS C TREATMENT
HEPATITIS B REACTIVATION DURING HEPATITIS C TREATMENT

Bárbara Morão  et al.

USE OF LIVER TRANSIENT ELASTOGRAPHY ON THE PREDICTION OF THE PRESENCE OF OESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE: IS THE AETIOLOGY RELEVANT?
USE OF LIVER TRANSIENT ELASTOGRAPHY ON THE PREDICTION OF THE PRESENCE OF OESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE: IS THE AETIOLOGY RELEVANT?

Bárbara Morão  et al.

EARLY INTERVENTION WITH BIOLOGICS IN CROHN'S DISEASE - HOW EARLY IS EARLY?
EARLY INTERVENTION WITH BIOLOGICS IN CROHN'S DISEASE - HOW EARLY IS EARLY?

Bárbara Morão  et al.

LESS IS MORE: THE IMPACT OF 2020 ESGE GUIDELINE ON POST PIECEMEAL EMR SURVEILLANCE
LESS IS MORE: THE IMPACT OF 2020 ESGE GUIDELINE ON POST PIECEMEAL EMR SURVEILLANCE

Bárbara Morão  et al.

ABC SCORE TO PREDICT LOWER GASTROINTESTINAL BLEEDING SEVERITY: A STEP IN THE RIGHT DIRECTION
ABC SCORE TO PREDICT LOWER GASTROINTESTINAL BLEEDING SEVERITY: A STEP IN THE RIGHT DIRECTION

Bárbara Morão  et al.

Item 1 - 20 / 23
1
2